d-Dimer testing to predict recurrence risk in venous thromboembolism: looking for a useful threshold: a rebuttal.
Le Gal
G
G
Bounameaux
H
H
D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage; D005338:Fibrin Fibrinogen Degradation Products / Q000378:metabolism*; D006801:Humans; D012372:ROC Curve; D012008:Recurrence; D012307:Risk Factors; D013923:Thromboembolism / Q000097:blood* / Q000188:drug therapy / Q000209:etiology*; D013997:Time Factors; D020246:Venous Thrombosis / Q000097:blood* / Q000188:drug therapy / Q000209:etiology*
D000925:Anticoagulants; D005338:Fibrin Fibrinogen Degradation Products; C036309:fibrin fragment D